AU2002252981A1 - Pharmaceutical compositions containing beta-mimetic agents and having few side-effects - Google Patents

Pharmaceutical compositions containing beta-mimetic agents and having few side-effects

Info

Publication number
AU2002252981A1
AU2002252981A1 AU2002252981A AU2002252981A AU2002252981A1 AU 2002252981 A1 AU2002252981 A1 AU 2002252981A1 AU 2002252981 A AU2002252981 A AU 2002252981A AU 2002252981 A AU2002252981 A AU 2002252981A AU 2002252981 A1 AU2002252981 A1 AU 2002252981A1
Authority
AU
Australia
Prior art keywords
effects
pharmaceutical compositions
compositions containing
few side
containing beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002252981A
Inventor
Karl-Heinz Bozung
Michel Pairet
Richard Reichl
Alexander Walland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharma GmbH and Co KG filed Critical BOEHRINGER INGELHEIM PHARMA
Publication of AU2002252981A1 publication Critical patent/AU2002252981A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002252981A 2001-02-01 2002-01-24 Pharmaceutical compositions containing beta-mimetic agents and having few side-effects Abandoned AU2002252981A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10104370A DE10104370A1 (en) 2001-02-01 2001-02-01 Medicinal compositions with fewer side effects
DE10104370.8 2001-02-01
PCT/EP2002/000704 WO2002060533A2 (en) 2001-02-01 2002-01-24 Pharmaceutical compositions containing beta-mimetic agents and having few side-effects

Publications (1)

Publication Number Publication Date
AU2002252981A1 true AU2002252981A1 (en) 2002-08-12

Family

ID=7672383

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002252981A Abandoned AU2002252981A1 (en) 2001-02-01 2002-01-24 Pharmaceutical compositions containing beta-mimetic agents and having few side-effects

Country Status (5)

Country Link
EP (1) EP1357976A2 (en)
AU (1) AU2002252981A1 (en)
CA (1) CA2436510A1 (en)
DE (1) DE10104370A1 (en)
WO (1) WO2002060533A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
WO2007017670A1 (en) 2005-08-08 2007-02-15 Argenta Discovery Ltd. Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
ES2298049B1 (en) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. PROCEDURE FOR MANUFACTURING BROMIDE OF 3 (R) - (2-HIDROXI-2,2-DITIEN-2-ILACETOXI) -1- (3-PHENOXIPROPIL) -1-AZONIABICICLO (2.2.2) OCTANO.
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
DE19827178A1 (en) * 1998-06-18 2000-04-27 Boehringer Ingelheim Pharma Stable aerosol formulations containing two or more bioactives used for pharmaceuticals

Also Published As

Publication number Publication date
CA2436510A1 (en) 2002-08-08
EP1357976A2 (en) 2003-11-05
DE10104370A1 (en) 2002-08-08
WO2002060533A2 (en) 2002-08-08
WO2002060533A3 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
AU2002313236A1 (en) Medicinal compositions
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
AU2002341205A1 (en) Pharmaceutical compositions comprising cyclosporin
AU2002302147A1 (en) Pharmaceutical composition
IL158671A0 (en) Benzyloxy derivatives and pharmaceutical compositions containing the same
AU2002258221A1 (en) Medicinal composition
AU2002214324A1 (en) Medicinal compositions
IL159006A0 (en) Phenoxy-phenyl derivatives and pharmaceutical compositions containing the same
AU2002252981A1 (en) Pharmaceutical compositions containing beta-mimetic agents and having few side-effects
AU2002254455A1 (en) Taxoid anti-tumor agents and pharmaceutical compositions thereof
AU4085201A (en) Pharmaceutical composition
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU4543500A (en) Pharmaceutical compositions and uses
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2002354460A1 (en) Medicinal composition
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
AU3586401A (en) Pharmaceutical composition
AU2001278705A1 (en) Pharmaceutical composition
AUPR529701A0 (en) Pharmaceutical composition
AU2001282541A1 (en) Medicinal compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase